Literature DB >> 29986083

Ophthalmic manifestations of giant cell arteritis.

Ivana Vodopivec1,2, Joseph F Rizzo3,4.   

Abstract

GCA, the most common systemic arteritis, affects medium-sized and larger extradural arteries that have the internal elastic lamina. Involvement of the ophthalmic artery and its branches results in visual loss, which is often complete but is usually painless. Visual loss may be monocular or binocular developing simultaneously or sequentially. Rarely, it stems from occipital lobe infarct that result in homonymous hemianopia, a visual field defect involving the two identical halves (right or left) of the visual fields of both eyes. Visual hallucinations and diplopia are less common. All visual symptoms, including those that are transient, require urgent ophthalmological evaluation and treatment with high-dose glucocorticoids to avoid permanent visual loss.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29986083     DOI: 10.1093/rheumatology/kex428

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  20 in total

1.  Characteristics of patients with giant cell arteritis who experience visual symptoms.

Authors:  Chung Shen Chean; James A Prior; Toby Helliwell; John Belcher; Sarah L Mackie; Samantha L Hider; Jennifer Liddle; Christian D Mallen
Journal:  Rheumatol Int       Date:  2019-08-22       Impact factor: 2.631

2.  Increased diagnostic accuracy of giant cell arteritis using three-dimensional fat-saturated contrast-enhanced vessel-wall magnetic resonance imaging at 3 T.

Authors:  Guillaume Poillon; Adrien Collin; Ygal Benhamou; Gaëlle Clavel; Julien Savatovsky; Cécile Pinson; Kevin Zuber; Frédérique Charbonneau; Catherine Vignal; Hervé Picard; Tifenn Leturcq; Sébastien Miranda; Thomas Sené; Emmanuel Gerardin; Augustin Lecler
Journal:  Eur Radiol       Date:  2019-12-06       Impact factor: 5.315

3.  Complex oculomotor nerves palsy and incidental ischemic stroke as atypical presentation of giant cell arteritis.

Authors:  Alessandro Miscioscia; Paola Decet; Annalisa Angelini; Diego Cecchin; Annachiara Cagnin
Journal:  Neurol Sci       Date:  2022-03-17       Impact factor: 3.830

Review 4.  Neuro-Ophthalmic Emergencies.

Authors:  Samuel J Spiegel; Heather E Moss
Journal:  Neurol Clin       Date:  2021-03-31       Impact factor: 3.806

Review 5.  Impact of Climate Change on Eye Diseases and Associated Economical Costs.

Authors:  Lucía Echevarría-Lucas; José Mᵃ Senciales-González; María Eloísa Medialdea-Hurtado; Jesús Rodrigo-Comino
Journal:  Int J Environ Res Public Health       Date:  2021-07-05       Impact factor: 3.390

6.  Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab.

Authors:  Kazusato Hara; Masataka Umeda; Keiko Segawa; Midori Akagi; Yushiro Endo; Tomohiro Koga; Shin-Ya Kawashiri; Kunihiro Ichinose; Hideki Nakamura; Takahiro Maeda; Atsushi Kawakami
Journal:  Intern Med       Date:  2021-10-05       Impact factor: 1.282

7.  Population-based Rate and Patterns of Diplopia in Giant Cell Arteritis.

Authors:  Clara M Castillejo Becerra; Cynthia S Crowson; Matthew J Koster; Kenneth J Warrington; M Tariq Bhatti; John J Chen
Journal:  Neuroophthalmology       Date:  2021-08-20

8.  Development of Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient with Hypereosinophilic Syndrome.

Authors:  Kayo Ishii; Takahiro Mizuuchi; Yusuke Yamamoto; Hiroaki Mori; Mayu Tago; Eri Kato; Haeru Hayashi; Koichiro Tahara; Tetsuji Sawada
Journal:  Intern Med       Date:  2020-02-26       Impact factor: 1.271

9.  Combined Left Central Retinal Artery Occlusion and Bilateral Anterior Ischemic Optic Neuritis: A Rare Presentation of Giant Cell Arteritis.

Authors:  Anne D D Joseph; Jebananthy Anandaselvam Pradeepan; Thirunavukarasu Kumanan; Muthusamy Malaravan
Journal:  Case Rep Rheumatol       Date:  2019-09-22

10.  Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements.

Authors:  Rosanna Dammacco; Giovanni Alessio; Ermete Giancipoli; Patrizia Leone; Anna Cirulli; Leonardo Resta; Angelo Vacca; Franco Dammacco
Journal:  Clin Ophthalmol       Date:  2020-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.